At present, the pharmaceutical market in the country is around Tk30,000 crore and the companies are exporting medicines to more than 100 countries
Wall Street is taking notice. The average forecast among analysts for Moderna’s 2022 revenue has jumped 35% since President Joe Biden laid out his booster plan in mid-August
The rise in imports and exports also reflects how pandemic brings opportunity for local drugmakers